Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh

Pyrazinamide (PZA) is a frontline antituberculosis (anti-TB) drug used in both first- and second-line treatment regimens. However, due to complex laboratory requirements, the PZA susceptibility test is rarely performed, leading to a scarcity of data on susceptibility to PZA. Bangladesh is a country...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Rahman, Arfatur, Ferdous, Sara Sabrina, Ahmed, Shahriar, Rahman, S. M. Mazidur, Uddin, Mohammad Khaja Mafij, Pholwat, Suporn, Gratz, Jean, Houpt, Eric, Banu, Sayera
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2017
Subjects:
Susceptibility
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571327/
https://ncbi.nlm.nih.gov/pubmed/28630193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00511-17
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items